| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |